1. Home
  2. BOKF vs PCVX Comparison

BOKF vs PCVX Comparison

Compare BOKF & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo BOK Financial Corporation

BOKF

BOK Financial Corporation

HOLD

Current Price

$134.53

Market Cap

8.0B

Sector

Finance

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$52.61

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BOKF
PCVX
Founded
1910
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.0B
7.0B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
BOKF
PCVX
Price
$134.53
$52.61
Analyst Decision
Hold
Strong Buy
Analyst Count
9
4
Target Price
$133.67
$88.25
AVG Volume (30 Days)
249.2K
1.3M
Earning Date
04-20-2026
05-07-2026
Dividend Yield
1.91%
N/A
EPS Growth
12.65
N/A
EPS
2.58
N/A
Revenue
N/A
N/A
Revenue This Year
$6.56
N/A
Revenue Next Year
$5.22
N/A
P/E Ratio
$51.50
N/A
Revenue Growth
N/A
N/A
52 Week Low
$96.89
$29.10
52 Week High
$139.73
$65.00

Technical Indicators

Market Signals
Indicator
BOKF
PCVX
Relative Strength Index (RSI) 58.41 57.90
Support Level $129.49 $52.04
Resistance Level $136.59 $56.04
Average True Range (ATR) 2.54 2.09
MACD 0.46 0.90
Stochastic Oscillator 84.74 89.73

Price Performance

Historical Comparison
BOKF
PCVX

About BOKF BOK Financial Corporation

BOK Financial Corp is a financial institution based in Oklahoma that offers a broad range of nationally competitive financial products and services. The company operates through three main segments: Commercial Banking, Consumer Banking, and Wealth Management. Commercial Banking provides lending, treasury and cash management, and risk management services, and includes the TransFund EFT network. Consumer Banking focuses on retail lending, deposit services, and mortgage loan origination and servicing. Wealth Management engages mainly in brokerage and trading activities, particularly in U.S. government agency mortgage-backed securities and related derivatives. The company generates the majority of its revenue from the Commercial Banking segment.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: